TCL Archive Preliminary estimates based on NLST results: Year Of Life Saved Could Cost $38,000 July 1, 2011
TCL Archive Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer February 29, 2008
TCL Archive Authorization Legislation Still On Congress Busy Agenda, Along With Risk Assessment, Appropriations February 3, 1984
TCL Archive FDA Throws Up IND Roadblock, Then Refuses To Answer Investigator’s Letters About It February 6, 1976
